Table 3 Microbial isolates from sternal wound (per‐protocol analysis).
No. of patients | Control group (n = 99) | Study group (n = 87) |
---|---|---|
With SWI | 25 | 8 |
With positive growth | 19 | 7 |
With multiple organisms | 10 | 5 |
With Gram‐positive bacteria* | 10† | 4† |
Staphylococcus aureus | 4 | 2 |
Enterococcus faecalis | 8 | 2 |
Number of Gram‐positive organisms resistant to cefuroxime | 2 | 2 |
Number of Gram‐positive organisms resistant to rifampicin | 4 | 1 |
Number of Gram‐positive organisms resistant to vancomycin | 0 | 0 |
With Gram‐negative bacteria | 15† | 7† |
Pseudomonas aeruginosa | 2 | 3 |
Bacteroides fragilis | 2 | 1 |
Enterobacteriaceae | 14 | 7 |
Enterobacter cloacae | 1 | 1 |
Escherichia coli | 12 | 5 |
Proteus mirabilis | 1 | 1 |
Klebsiella pneumoniae | 0 | 2 |
Serratia marcescens | 0 | 1 |
With other organisms | ||
Candida albicans | 1 | 0 |
SWI, sternal wound infection.
*Flucloxacillin was often used as the preferred treatment, blind, and may have contributed to the low number of isolates.
†Patients may have more than one organism.